Clinical Trial Management System Industry - Current Vs Emerging Trends | Future Forecasts


Posted November 26, 2019 by mmvaidya01

Key players in the clinical trial management systems market include Oracle Corporation (US); Medidata Solutions, Inc. (US); PAREXEL International Corporation, (US); Bioclinica, (US); Bio-Optronics, Inc. (US); and IBM (US); among others.

 
The major factors driving the growth of the CTMS market include the significant partnerships between Asian CROs and pharma companies, rising number of clinical trials in both developing and developed nations, availability of advanced and upgraded CTMS solutions, and rising government support for clinical trials in Asian countries.

The global clinical trial management system market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%.

Target Audience:

# Healthcare IT service providers
# Pharmaceutical/biopharmaceutical companies
# Clinical research organizations
# Research and development (R&D) companies
# Medical device companies
# Business research and consulting service providers
# Academic medical centers/universities/hospitals

Please Share Your Specific Interest to Serve You Better | Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=470

Critical Questions This Report Answers:

# Which of the end user segments would be driving the market growth during next decade for these software solutions; especially in Emerging countries?

# Emerging countries have immense opportunities for the growth of web-based (on-demand) segment, will this scenario continue?

# The enterprise-wise CTMS segment is expected to command the largest share across matured countries; how relevant On-Site CTMS solutions would be with changing user preferences?

# By how much is the clinical trial data management software segment larger than the services segment during 2017-2022?

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2027). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.

Analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the CTMS market. Among these business strategies, product enhancements, agreements, and partnerships were the most widely adopted growth strategies by the players in the CTMS market.

Please Share Your Specific Interest to Serve You Better | Get the Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=470

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Phone 8886006441
Business Address 630 Dundee Road
https://www.marketsandmarkets.com/
Country United States
Categories Industry , Medical , News
Tags clinical trial management system market
Last Updated November 26, 2019